{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:10:04Z","timestamp":1778170204731,"version":"3.51.4"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran Medical University of Medical Sciences, Mazandaran, Iran","doi-asserted-by":"publisher","award":["1402.177713"],"award-info":[{"award-number":["1402.177713"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MIRNA"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The COG complex is implicated in the tethering of retrograde intra-Golgi vesicles, which involves vesicular tethering and SNAREs. SNARE complexes mediate the inva-sion and metastasis of cancer cells through MMPs which activate growth factors for ECM frag-ments by binding to integrin receptors. Increasing MMPs is in line with YKL40 since YKL40 is linked to promoting angiogenesis through VEGF and can increase ovarian cancer (OC) resistance to chemotropic and cell migration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study is an assessment of siRNA-COG3 on proliferation, invasion, and apoptosis of OC cells. In addition, siRNA-COG3 may prevent the growth of OC cancer in mice with tumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Primary OC cell lines will be treated with siRNA-COG3 to assay YKL40 and identified angiogenesis by Tube-like structure formation in HOMECs. The Golgi morphology was analyzed using Immunofluorescence microscopy. Furthermore, the effects of siRNA-COG3 on the prolifer-ation and apoptosis of cells were evaluated using MTT and TUNEL assays. Clones of the HOSEpiC OC cell line were subcutaneously implanted in FVB\/N mice. Mice were treated after two weeks of injection of cells using siRNA-COG3. Tumor development suppression was detected by D-luciferin. RT-PCR and western blotting analyses were applied to determine COG3, MT1-MMP, SNAP23, and YKL40 expression to investigate the effects of COG3 gene knockdown.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>siRNA-COG3 exhibited a substantial effect in suppressing tumor growth in mice. It dra-matically reduced OC cell proliferation and triggered apoptosis (all p &lt; 0.01). Inhibition of COG3, YKL-40, and MT1-MPP led to suppression of angiogenesis and reduction of microvessel density through SNAP23 in OC cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Overall, by knockdown of the COG3 gene, MT1-MMP and YKL40 were dropped, leading to suppressed angiogenesis along with decreasing migration and proliferation. SiRNA-COG3 may be an ideal agent to consider for clinical trial assessment therapy for OC, especially when an antiangiogenic SNAR-pathway targeting drug.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0122115366275856240101083442","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T05:04:32Z","timestamp":1705813472000},"page":"140-154","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor Targeting <i>via<\/i> siRNA-COG3 to Suppress Tumor Progression in Mice\nand Inhibit Cancer Metastasis and Angiogenesis in Ovarian Cancer Cell\nLines"],"prefix":"10.2174","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-5757","authenticated-orcid":true,"given":"Janat","family":"Ijabi","sequence":"first","affiliation":[{"name":"Department of Hematology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Hematology, Faculty of Medicine and Health Sciences, University Sains Malaysia, Kubang Kerian, 15200 Kota Bharu, Kelantan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1659-761X","authenticated-orcid":true,"given":"Roghayeh","family":"Ijabi","sequence":"additional","affiliation":[{"name":"Faculty of Reproductive Health, Golestan University of Medical Sciences, Gorgan, Iran"},{"name":"Department of Pharmacology, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-9341","authenticated-orcid":true,"given":"Parisa","family":"Roozehdar","sequence":"additional","affiliation":[{"name":"Department of Medical Veterinary, Azad University, Garmsar Branch, Garmsar, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-1301","authenticated-orcid":true,"given":"Zachary A.","family":"Kaminsky","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Cellular and Molecular Medicine, Royal\u2019s Institute of Mental Health Research, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-4445","authenticated-orcid":true,"given":"Hemen","family":"Moradi-Sardareh","sequence":"additional","affiliation":[{"name":"Department of Basic Sciences, Asadabad School of Medical Sciences, Hamedan University of Medical Sciences, Hamedan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0909-124X","authenticated-orcid":true,"given":"Najmeh","family":"Tehranian","sequence":"additional","affiliation":[{"name":"Department of Midwifery &amp; Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Jalal Ale Ahmad Highway, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-4092","authenticated-orcid":true,"given":"Naveed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"Yeung T.L.","year":"2015","unstructured":"Yeung T.L.; Leung C.S.; Yip K.P.; Au Yeung C.L.; Wong S.T.C.; Mok S.C.; Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol  2015,309(7),C444-C456","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e146186","DOI":"10.1172\/JCI146186","volume":"131","author":"Qian J.","year":"2021","unstructured":"Qian J.; LeSavage B.L.; Hubka K.M.; Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest  2021,131(16),e146186","journal-title":"J Clin Invest"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4331\/wjbc.v5.i3.355","volume":"5","author":"Verma S.","year":"2014","unstructured":"Verma S.; Kesh K.; Ganguly N.; Jana S.; Swarnakar S.; Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem  2014,5(3),355-376","journal-title":"World J Biol Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"Quintero-Fabi\u00e1n S.","year":"2019","unstructured":"Quintero-Fabi\u00e1n S.; Arreola R.; Becerril-Villanueva E.; Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol  2019,9,1370","journal-title":"Front Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ygyno.2008.09.025","volume":"112","author":"Adley B.P.","year":"2009","unstructured":"Adley B.P.; Gleason K.J.; Yang X.J.; Stack M.S.; Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma. Gynecol Oncol  2009,112(2),319-324","journal-title":"Gynecol Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"Cabral-Pacheco G.A.","year":"2020","unstructured":"Cabral-Pacheco G.A.; Garza-Veloz I.; Castruita-De la Rosa C.; The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci  2020,21(24),9739","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"Kessenbrock K.","year":"2010","unstructured":"Kessenbrock K.; Plaks V.; Werb Z.; Matrix metalloproteinases: regulators of the tumor microenvironment. Cell  2010,141(1),52-67","journal-title":"Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/09687860500143829","volume":"22","author":"Wang Y.","year":"2005","unstructured":"Wang Y.; Tai G.; Lu L.; Johannes L.; Hong W.; Luen Tang B.; Trans-Golgi network syntaxin 10 functions distinctly from syntaxins 6 and 16. Mol Membr Biol  2005,22(4),313-325","journal-title":"Mol Membr Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"679955","DOI":"10.3389\/fonc.2021.679955","volume":"11","author":"Gorshtein G.","year":"2021","unstructured":"Gorshtein G.; Grafinger O.; Coppolino M.G.; Targeting SNARE-mediated vesicle transport to block invadopodium-based cancer cell invasion. Front Oncol  2021,11,679955","journal-title":"Front Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1091\/mbc.e13-10-0582","volume":"25","author":"Williams K.C.","year":"2014","unstructured":"Williams K.C.; McNeilly R.E.; Coppolino M.G.; SNAP23, Syntaxin4, and vesicle-associated membrane protein 7 (VAMP7) mediate trafficking of membrane type 1\u2013matrix metalloproteinase (MT1-MMP) during invadopodium formation and tumor cell invasion. Mol Biol Cell  2014,25(13),2061-2070","journal-title":"Mol Biol Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1600-0854.2003.00151.x","volume":"5","author":"Burri L.","year":"2004","unstructured":"Burri L.; Lithgow T.; A complete set of SNAREs in yeast. Traffic  2004,5(1),45-52","journal-title":"Traffic"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1091\/mbc.e10-05-0457","volume":"21","author":"Ohashi Y.","year":"2010","unstructured":"Ohashi Y.; Munro S.; Membrane delivery to the yeast autophagosome from the Golgi-endosomal system. Mol Biol Cell  2010,21(22),3998-4008","journal-title":"Mol Biol Cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrm2417","volume":"9","author":"Martens S.","year":"2008","unstructured":"Martens S.; McMahon H.T.; Mechanisms of membrane fusion: disparate players and common principles. Nat Rev Mol Cell Biol  2008,9(7),543-556","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13300","DOI":"10.1074\/jbc.271.23.13300","volume":"271","author":"Ravichandran V.","year":"1996","unstructured":"Ravichandran V.; Chawla A.; Roche P.A.; Identification of a novel syntaxin- and synaptobrevin\/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J Biol Chem  1996,271(23),13300-13303","journal-title":"J Biol Chem"},{"key":"ref=15","first-page":"351","volume":"110","author":"Volck B.","year":"1998","unstructured":"Volck B.; Price P.A.; Johansen J.S.; YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians  1998,110(4),351-360","journal-title":"Proc Assoc Am Physicians"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fphys.2013.00122","volume":"4","author":"Shao R.","year":"2013","unstructured":"Shao R.; YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol  2013,4,122","journal-title":"Front Physiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1533033818765209","author":"Fuksiewicz M.","year":"2018","unstructured":"Fuksiewicz M.; Kotowicz B.; Rutkowski A.; Achinger-Kawecka J.; Wagrodzki M.; Kowalska M.M.; The assessment of clinical usage and prognostic value of YKL-40 serum levels in patients with rectal cancer without distant metastasis. Technol Cancer Res Treat  2018,17","journal-title":"Technol Cancer Res Treat"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1590\/S0100-879X2010007500133","volume":"43","author":"Zou L.","year":"2010","unstructured":"Zou L.; He X.; Zhang J.W.; The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res  2010,43(12),1232-1238","journal-title":"Braz J Med Biol Res"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-1065-2_19","author":"Gupta RK","year":"2012","unstructured":"Gupta RK; Gupta G;  Chi-lectins: forms, functions and clinical applications  2012","journal-title":"Chi-lectins: forms, functions and clinical applications"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e63779","DOI":"10.1371\/journal.pone.0063779","volume":"8","author":"Patil D.N.","year":"2013","unstructured":"Patil D.N.; Datta M.; Dev A.; Structural investigation of a novel N-acetyl glucosamine binding chi-lectin which reveals evolutionary relationship with class III chitinases. PLoS One  2013,8(5),e63779","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.carres.2008.01.034","volume":"343","author":"Smith R.D.","year":"2008","unstructured":"Smith R.D.; Lupashin V.V.; Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation. Carbohydr Res  2008,343(12),2024-2031","journal-title":"Carbohydr Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fnins.2015.00405","volume":"9","author":"Climer L.K.","year":"2015","unstructured":"Climer L.K.; Dobretsov M.; Lupashin V.; Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function. Front Neurosci  2015,9,405","journal-title":"Front Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1083\/jcb.200202016","volume":"157","author":"Ungar D.","year":"2002","unstructured":"Ungar D.; Oka T.; Brittle E.E.; Characterization of a mammalian Golgi-localized protein complex, COG, that is required for normal Golgi morphology and function. J Cell Biol  2002,157(3),405-415","journal-title":"J Cell Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0171-9335(98)80012-5","volume":"76","author":"Valderrama F.","year":"1998","unstructured":"Valderrama F.; Babi\u00e0 T.; Ayala I.; Kok J.W.; Renau-Piqueras J.; Egea G.; Actin microfilaments are essential for the cytological positioning and morphology of the Golgi complex. Eur J Cell Biol  1998,76(1),9-17","journal-title":"Eur J Cell Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e1006140","DOI":"10.1371\/journal.pgen.1006140","volume":"12","author":"Tan X.","year":"2016","unstructured":"Tan X.; Cao K.; Liu F.; Arabidopsis COG complex subunits COG3 and COG8 modulate Golgi morphology, vesicle trafficking homeostasis and are essential for pollen tube growth. PLoS Genet  2016,12(7),e1006140","journal-title":"PLoS Genet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/ncomms2535","volume":"4","author":"Willett R.","year":"2013","unstructured":"Willett R.; Kudlyk T.; Pokrovskaya I.; COG complexes form spatial landmarks for distinct SNARE complexes. Nat Commun  2013,4(1),1553","journal-title":"Nat Commun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/1873-3468.13570","volume":"593","author":"Blackburn J.B.","year":"2019","unstructured":"Blackburn J.B.; D\u2019Souza Z.; Lupashin V.V.; Maintaining order: COG complex controls Golgi trafficking, processing, and sorting. FEBS Lett  2019,593(17),2466-2487","journal-title":"FEBS Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1083\/jcb.200412003","volume":"168","author":"Zolov S.N.","year":"2005","unstructured":"Zolov S.N.; Lupashin V.V.; Cog3p depletion blocks vesicle-mediated Golgi retrograde trafficking in HeLa cells. J Cell Biol  2005,168(5),747-759","journal-title":"J Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-021-00489-x","volume":"7","author":"Qian L.","year":"2021","unstructured":"Qian L.; Yang X.; Li S.; Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer. Cell Death Discov  2021,7(1),112","journal-title":"Cell Death Discov"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1182\/blood-2010-06-291690","volume":"117","author":"Manickam V.","year":"2011","unstructured":"Manickam V.; Tiwari A.; Jung J.J.; Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood  2011,117(4),1425-1435","journal-title":"Blood"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13048-016-0289-9","volume":"9","author":"Sun Q.","year":"2016","unstructured":"Sun Q.; Huang X.; Zhang Q.; SNAP23 promotes the malignant process of ovarian cancer. J Ovarian Res  2016,9(1),80","journal-title":"J Ovarian Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"29139","DOI":"10.1038\/srep29139","volume":"6","author":"Willett R.","year":"2016","unstructured":"Willett R.; Blackburn J.B.; Climer L.; COG lobe B sub-complex engages v-SNARE GS15 and functions via regulated interaction with lobe A sub-complex. Sci Rep  2016,6(1),29139","journal-title":"Sci Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2015.00004","volume":"3","author":"Jacob A.","year":"2015","unstructured":"Jacob A.; Prekeris R.; The regulation of MMP targeting to invadopodia during cancer metastasis. Front Cell Dev Biol  2015,3,4","journal-title":"Front Cell Dev Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-313X.1998.00208.x","volume":"15","author":"Boevink P.","year":"1998","unstructured":"Boevink P.; Oparka K.; Cruz S.S.; Martin B.; Betteridge A.; Hawes C.; Stacks on tracks: The plant Golgi apparatus traffics on an actin\/ER network. Plant J  1998,15(3),441-447","journal-title":"Plant J"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jipb.12077","volume":"55","author":"Gu F","year":"2013","unstructured":"Gu F ; Nielsen EJJoIPB. Targeting and regulation of cell wall synthesis during tip growth in plants. J Integr Plant Biol  2013,55(9),835-846","journal-title":"J Integr Plant Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0854.2005.00376.x","volume":"7","author":"Shestakova A.","year":"2006","unstructured":"Shestakova A.; Zolov S.; Lupashin V.J.T.; COG complex\u2010mediated recycling of Golgi glycosyltransferases is essential for normal protein glycosylation. Traffic  2006,7(2),191-204","journal-title":"Traffic"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"e27888","DOI":"10.4161\/cl.27888","volume":"4","author":"Willett R.","year":"2014","unstructured":"Willett R.; Pokrovskaya I.; Kudlyk T.; Lupashin V.; Multipronged interaction of the COG complex with intracellular membranes. Cell Logist  2014,4(1),e27888","journal-title":"Cell Logist"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/tra.12093","volume":"14","author":"Laufman O.","year":"2013","unstructured":"Laufman O.; Freeze H.H.; Hong W.; Lev S.; Deficiency of the Cog8 subunit in normal and CDG-derived cells impairs the assembly of the COG and Golgi SNARE complexes. Traffic  2013,14(10),1065-1077","journal-title":"Traffic"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1172\/JCI6870","volume":"103","author":"Stetler-Stevenson W.G.","year":"1999","unstructured":"Stetler-Stevenson W.G.; Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest  1999,103(9),1237-1241","journal-title":"J Clin Invest"},{"key":"ref=40","first-page":"551","volume":"9","author":"Rundhaug J.E.","year":"2003","unstructured":"Rundhaug J.E.; Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, A broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003. Clin Cancer Res  2003,9(2),551-554","journal-title":"Clin Cancer Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biopha.2018.02.050","volume":"100","author":"Pouyafar A.","year":"2018","unstructured":"Pouyafar A.; Heydarabad M.Z.; Mahboob S.; Mokhtarzadeh A.; Rahbarghazi R.; Angiogenic potential of YKL-40 in the dynamics of tumor niche. Biomed Pharmacother  2018,100,478-485","journal-title":"Biomed Pharmacother"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"40507","DOI":"10.18632\/oncotarget.5943","volume":"6","author":"Shao R.","year":"2015","unstructured":"Shao R.; Taylor S.L.; Oh D.S.; Schwartz L.M.; Vascular heterogeneity and targeting: The role of YKL-40 in glioblastoma vascularization. Oncotarget  2015,6(38),40507-40518","journal-title":"Oncotarget"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","volume":"81","author":"Wang X.","year":"2018","unstructured":"Wang X.; Khalil R.A.; Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv Pharmacol  2018,81,241-330","journal-title":"Adv Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1158\/1535-7163.MCT-10-0868","volume":"72","author":"Faibish M.","year":"2012","unstructured":"Faibish M.; Francescone R.; Bentley B.; Yan W.; Shao R.A.; YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: A potential therapeutic agent in cancers. Cancer Res  2012,72(8),4620-0","journal-title":"Cancer Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s11626-019-00403-x","volume":"55","author":"Morera E.","year":"2019","unstructured":"Morera E.; Steinh\u00e4user S.S.; Budkova Z.; YKL-40\/CHI3L1 facilitates migration and invasion in HER2 overexpressing breast epithelial progenitor cells and generates a niche for capillary-like network formation. In vitro Cell Dev Biol Anim  2019,55(10),838-853","journal-title":"In vitro Cell Dev Biol Anim"}],"container-title":["MicroRNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122115366275856240101083442","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225751\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122115366275856240101083442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:26:20Z","timestamp":1727936780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225751\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0122115366275856240101083442","relation":{},"ISSN":["2211-5366"],"issn-type":[{"value":"2211-5366","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}